These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38190264)

  • 1. Prevalent vs Incident Screen: Why Does It Matter?
    Hayward JH; Lee AY; Sickles EA; Ray KM
    J Breast Imaging; 2024 May; 6(3):232-237. PubMed ID: 38190264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
    Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
    Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from 10 years of breast screening in Wales.
    Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
    J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.
    Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
    Breast; 2020 Dec; 54():343-348. PubMed ID: 33023825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
    Lowry KP; Coley RY; Miglioretti DL; Kerlikowske K; Henderson LM; Onega T; Sprague BL; Lee JM; Herschorn S; Tosteson ANA; Rauscher G; Lee CI
    JAMA Netw Open; 2020 Jul; 3(7):e2011792. PubMed ID: 32721031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Skaane P; Sebuødegård S; Bandos AI; Gur D; Østerås BH; Gullien R; Hofvind S
    Breast Cancer Res Treat; 2018 Jun; 169(3):489-496. PubMed ID: 29429017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.
    Beckmann K; Duffy SW; Lynch J; Hiller J; Farshid G; Roder D
    J Med Screen; 2015 Sep; 22(3):127-35. PubMed ID: 25896926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women.
    Sripaiboonkij N; Thinkamrop B; Promthet S; Kannawat C; Tangcharoensathien V; Ansusing T; Rattanamongkolgul S
    Asian Pac J Cancer Prev; 2016; 17(8):4137-41. PubMed ID: 27644674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of invasive breast cancers detected by screening mammography.
    Zahl PH; Maehlen J; Welch HG
    Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple way to measure the burden of interval cancers in breast cancer screening.
    Andersen SB; Törnberg S; Lynge E; Von Euler-Chelpin M; Njor SH
    BMC Cancer; 2014 Oct; 14():782. PubMed ID: 25344115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancers missed in the prevalent screening round: effect upon the size distribution of incident round detected cancers.
    Maxwell AJ
    J Med Screen; 1999; 6(1):28-9. PubMed ID: 10321367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evaluation of an organised mammography screening program in Greece 2004-2009.
    Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
    Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea.
    Hong JL; Henderson LM; Jonsson Funk M; Lund JL; Buse JB; Pate V; Stürmer T
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):666-675. PubMed ID: 28370798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.
    Steponaviciene L; Vincerzevskiene I; Briediene R; Urbonas V; Vanseviciute-Petkeviciene R; Smailyte G
    Cancer Control; 2019; 26(1):1073274819874122. PubMed ID: 31502471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.